Physician

Nathan Farley, MD

According to 2025 Medicare claims, Nathan Farley, MD (NPI: 1427476035) practices ophthalmology in the Traverse City, MI market, with the plurality of this provider's patient population coming from Grand Traverse, MI. This provider's primary affiliated billing organization is ASSOCIATED RETINAL CONSULTANTS, PC (NPI: 1215003793; TIN: 381946761) and primary practice location at 49686-2704.

Farley's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 806 traditional Medicare patients, billed 28,979 HCPCS/CPT codes, and received $2,936,379 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 852 prescription claims across 269 beneficiaries totaling $32,065 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 32 records totaling $40,151. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $8,687 to $2,936,379. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.5M$3.1M2018 Medicare payment: $8,687 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $26,816 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $326,795 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,686,368 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,882,511 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,082,416 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,936,379 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20184472$8,687
2019153308$26,816
20203321,693$326,795
20216987,416$1,686,368
202285512,062$2,882,511
202382126,795$3,082,416
202480628,979$2,936,379

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$25K$50K2015 Drug cost: $7,762 (USD; Tot_Drug_Cst)2016 Drug cost: $16,461 (USD; Tot_Drug_Cst)2017 Drug cost: $50,452 (USD; Tot_Drug_Cst)2018 Drug cost: $47,597 (USD; Tot_Drug_Cst)2019 Drug cost: $29,200 (USD; Tot_Drug_Cst)2020 Drug cost: $31,121 (USD; Tot_Drug_Cst)2021 Drug cost: $35,831 (USD; Tot_Drug_Cst)2022 Drug cost: $37,415 (USD; Tot_Drug_Cst)2023 Drug cost: $35,882 (USD; Tot_Drug_Cst)2024 Drug cost: $32,065 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201549112$7,762
2016103319$16,461
2017211829$50,452
2018206890$47,597
2019245550$29,200
2020205513$31,121
2021225725$35,831
2022250755$37,415
2023236776$35,882
2024269852$32,065

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg2312,178$654
67028Injection of drug into eye3931,580$97
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more5681,376$94
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more266445$64
92134Imaging of retina7022,108$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate28713,683$13,993
DifluprednateDifluprednate491,674$4,796
Ketorolac TromethamineKetorolac Tromethamine1235,682$2,837
BrinzolamideBrinzolamide11791$1,628
Dorzolamide HclDorzolamide Hcl473,508$1,034

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.27$2,172Alimera Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.5$37,979Apellis Pharmaceuticals, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Nathan Farley, MD?

Tedicare shows public-source Medicare data for Nathan Farley, MD (NPI 1427476035), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nathan Farley, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nathan Farley, MD?

Nathan Farley, MD is linked to ASSOCIATED RETINAL CONSULTANTS, PC (billing NPI 1215003793) in the available physician profile data.

Does Nathan Farley, MD have Open Payments data?

Nathan Farley, MD has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.